Evidence map›Paper›PMID 38191441›Full record

ArticleBiological research2024

Alpha-synuclein dynamics bridge Type-I Interferon response and SARS-CoV-2 replication in peripheral cells.

Fiona Limanaqi, Silvia Zecchini, Irma Saulle, Sergio Strizzi, Claudia Vanetti, Micaela Garziano, Gioia Cappelletti, Debora Parolin, Sonia Caccia, Daria Trabattoni and 3 more

Open access · goldAbstract read
In one paragraph

Article in Biological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Review
  3. The neuroimmune system and cognition.Nature immunology · 2026
    Review
  4. Review
  5. Article
  6. iPSC-derived human cortical organoids display profound alterations of cellular homeostasis following SARS-CoV-2 infection and Spike protein exposure.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  7. Observational
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Fiona LimanaqiDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy. fiona.limanaqi@unimi.it.ORCID http://orcid.org/0000-0003-0185-2099
Silvia ZecchiniDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy.
Irma SaulleDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy.
Sergio StrizziDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy.
Claudia VanettiDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy.
Micaela GarzianoDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy.
Gioia CappellettiDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy.
Debora ParolinDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy.
Sonia CacciaDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy.
Daria TrabattoniDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy.
Claudio FeniziaDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy.
Mario ClericiDepartment of Pathophysiology and Transplantation, University of Milan, Via Francesco Sforza, Milan, Italy.
Mara BiasinDepartment of Biomedical and Clinical Sciences, University of Milan, Via G.B. Grassi, Milan, Italy. mara.biasin@unimi.it.
University of Milan · IT

Funding

NCEZID CDC HHS PE00000007 INF-ACT
6 · The paper itself

Abstract

backgroundIncreasing evidence suggests a double-faceted role of alpha-synuclein (α-syn) following infection by a variety of viruses, including SARS-CoV-2. Although α-syn accumulation is known to contribute to cell toxicity and the development and/or exacerbation of neuropathological manifestations, it is also a key to sustaining anti-viral innate immunity. Consistently with α-syn aggregation as a hallmark of Parkinson's disease, most studies investigating the biological function of α-syn focused on neural cells, while reports on the role of α-syn in periphery are limited, especially in SARS-CoV-2 infection.

resultsResults herein obtained by real time qPCR, immunofluorescence and western blot indicate that α-syn upregulation in peripheral cells occurs as a Type-I Interferon (IFN)-related response against SARS-CoV-2 infection. Noteworthy, this effect mostly involves α-syn multimers, and the dynamic α-syn multimer:monomer ratio. Administration of excess α-syn monomers promoted SARS-CoV-2 replication along with downregulation of IFN-Stimulated Genes (ISGs) in epithelial lung cells, which was associated with reduced α-syn multimers and α-syn multimer:monomer ratio. These effects were prevented by combined administration of IFN-β, which hindered virus replication and upregulated ISGs, meanwhile increasing both α-syn multimers and α-syn multimer:monomer ratio in the absence of cell toxicity. Finally, in endothelial cells displaying abortive SARS-CoV-2 replication, α-syn multimers, and multimer:monomer ratio were not reduced following exposure to the virus and exogenous α-syn, suggesting that only productive viral infection impairs α-syn multimerization and multimer:monomer equilibrium.

conclusionsOur study provides novel insights into the biology of α-syn, showing that its dynamic conformations are implicated in the innate immune response against SARS-CoV-2 infection in peripheral cells. In particular, our results suggest that promotion of non-toxic α-syn multimers likely occurs as a Type-I IFN-related biological response which partakes in the suppression of viral replication. Further studies are needed to replicate our findings in neuronal cells as well as animal models, and to ascertain the nature of such α-syn conformations.

Indexed as

alpha-SynucleinCOVID-19Interferon Type ISARS-CoV-2Cell LineEndothelial CellsHumansVirus Replicationalpha-SynucleinInterferon Type IAlpha-synuclein multimer:monomer ratioAlpha-synuclein (SNCA)Endothelial cellsEpithelial lung cellsInterferon Stimulated Genes (ISG)PBMC-epithelial cell co-culturePeripheral blood mononuclear cells (PBMC)Viral infection

Identifiers

PMID38191441
PMCPMC10775536
OpenAlexW4390685096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.